Enlivex Therapeutics Ltd. Quarterly Other Liabilities, Noncurrent in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Enlivex Therapeutics Ltd. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2017 to Q2 2024.
  • Enlivex Therapeutics Ltd. Other Liabilities, Noncurrent for the quarter ending June 30, 2024 was $499K.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $499K Jun 30, 2024 6-K 2024-08-30
Q4 2023 $686K -$3.51M -83.6% Dec 31, 2023 6-K 2024-08-30
Q4 2022 $4.19M Dec 31, 2022 20-F 2024-04-30
Q4 2018 $192K -$152K -44.2% Dec 31, 2018 20-F 2020-04-30
Q4 2017 $344K Dec 31, 2017 20-F 2019-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.